Neumora Therapeutics, Inc. (NMRA)
0.3672
-0.02
(-5.43%)
USD |
NASDAQ |
Oct 30, 16:00
0.3673
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Total Liabilities (Quarterly) : 80.73M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.73M |
| March 31, 2026 | 83.20M |
| December 31, 2025 | 87.28M |
| September 30, 2025 | 45.67M |
| June 30, 2025 | 40.95M |
| March 31, 2025 | 28.38M |
| December 31, 2024 | 29.91M |
| September 30, 2024 | 31.80M |
| June 30, 2024 | 23.21M |
| Date | Value |
|---|---|
| March 31, 2024 | 25.67M |
| December 31, 2023 | 27.12M |
| September 30, 2023 | 32.06M |
| June 30, 2023 | 29.81M |
| March 31, 2023 | 26.33M |
| December 31, 2022 | 29.40M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 19.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint, Inc. | 61.78M |
| Context Therapeutics, Inc. | 7.962M |
| LENZ Therapeutics, Inc. | -- |
| BioAge Labs, Inc. | 22.02M |
| ANI Pharmaceuticals, Inc. | 896.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.25M |
| Shareholders Equity (Quarterly) | 44.52M |
| Debt to Equity Ratio | 1.196 |
| Current Ratio | 4.496 |
| Net Debt Paydown Yield | -3.29% |